An enteropathogenic microbial toxin modulates the breast cancer epigenome resulting in concurrent silencing of tumor suppressor genes [PDF]
Background Recent studies have determined a close association between host microbiota and breast cancer initiation, growth and therapeutic outcomes.
Deepak Verma +4 more
doaj +2 more sources
Anaerobic gut bacteria and their potential role in the initiation, exacerbation, and development of human colorectal cancer: a narrative review [PDF]
Colorectal cancer (CRC) is known as the second leading cause of cancer-related deaths around the world. Rectal bleeding, changes in bowel movements, weight loss, and fatigue are the main clinical presentations of CRC.
Sahar Sabour +6 more
doaj +2 more sources
Gut microbiota and colorectal cancer: mechanistic insights, diagnostic advances, and microbiome-based therapeutic strategies [PDF]
Colorectal cancer (CRC) is closely linked to gut microbiota dysbiosis. We synthesize evidence that carcinogenic microbes promote CRC through chronic inflammation, bacterial genotoxins, and metabolic imbalance, highlighting key pathways involving ...
Bingbing Bai +59 more
doaj +2 more sources
Outer Membrane Vesicles From <i>Bacteroides fragilis</i> Contain Coding and Non-Coding Small RNA Species That Modulate Inflammatory Signalling in Intestinal Epithelial Cells. [PDF]
Outer membrane vesicles (OMVs) from Bacteroides fragilis carry distinct coding and non‐coding RNAs that influence host inflammatory signaling. Extravesicular RNAs from OMVs suppress IL‐8 expression in intestinal epithelial cells, while removal of these RNAs enhances pro‐inflammatory IL‐8 responses.
Sheikh A +20 more
europepmc +2 more sources
The tumor-microbe connection. [PDF]
Tumor‐associated bacteria (TAB) dynamically influence cancer biology by modulating tumor progression, metastatic spread, and therapeutic efficacy. Their presence redefines the tumor microenvironment (TME) as a microbial–host interface, yet mechanistic insights remain limited. Understanding TAB colonization routes, functional impacts, and crosstalk with
Vella G, Rescigno M.
europepmc +2 more sources
Repositioning small molecule drugs as allosteric inhibitors of the BFT-3 toxin from enterotoxigenic Bacteroides fragilis [PDF]
Bacteroides fragilis is an abundant commensal component of the healthy human colon. However, under dysbiotic conditions, enterotoxigenic B. fragilis (ETBF) may arise and elicit diarrhea, anaerobic bacteremia, inflammatory bowel disease, and colorectal ...
Abian, Olga +7 more
core +1 more source
Enterotoxigenic Bacteroides fragilis (ETBF) produces Bacteroides fragilis toxin (BFT), which is associated with acute diarrheal, inflammatory bowel disease, and colorectal cancer (CRC).
Samin Zamani +7 more
doaj +1 more source
Structure of the gut microbiome following colonization with human feces determines colonic tumor burden [PDF]
Background A growing body of evidence indicates that the gut microbiome plays a role in the development of colorectal cancer (CRC). Patients with CRC harbor gut microbiomes that are structurally distinct from those of healthy individuals;
Baxter, Nielson T +3 more
core +3 more sources
Background Enterotoxigenic Bacteroides fragilis (ETBF) has been implicated in colorectal carcinogenesis through the actions of its toxin, B. fragilis toxin (BFT).
Rachel V. Purcell +2 more
doaj +1 more source
Distinct interactions with cellular E-cadherin of the two virulent metalloproteinases encoded by a Bacteroides fragilis pathogenicity island. [PDF]
Bacteroides fragilis causes the majority of Gram-negative anaerobic infections in the humans. The presence of a short, 6-kb, pathogenicity island in the genome is linked to enterotoxigenic B. fragilis (ETBF). The role of the enterotoxin in B.
Albert G Remacle +2 more
doaj +1 more source

